INZYMES ApS: Financial statements 2024
CVR: 44272113
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
INZYMES ApS (CVR 44272113) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -5,296,729 and a net result of DKK -7,166,675. Equity in the 2024 report amounted to DKK 9,452,196. The solvency ratio was 90.1%. The company had 3 employees in the financial year.
- Gross Profit
- DKK -5,296,729
- Profit/Loss
- DKK -7,166,675
- Equity
- DKK 9,452,196
- Total Assets
- DKK 10,490,748
- Employees
- 3
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
INZYMES ApS has published its interim report for the period September 1, 2023 – December 31, 2023.
About INZYMES ApS
INZYMES ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2023. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Johannes Maarten van den Brink, Jonas Jacobsen and Michael Fooken Jensen. The board consists of Carlo Appennini (chair), Iris Verga, Johannes Maarten van den Brink and Michael Fooken Jensen. The company is owned by HJM Holding ApS and SACCO S.R.L.. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -1,085,350 and a net result of DKK -1,450,830 compared with DKK -7,166,675 the year before. Equity in the 2025 report amounted to DKK -184,269.